CYTK — Cytokinetics, Incorporated stock price, charts and financials

QT60Cytokinetics, Incorporated

Cytokinetics, Incorporated (NASDAQ: CYTK) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
68.78
-1.14-1.63%
OverviewShort InterestFilings
CYTKQT60Cytokinetics, Incorporated·NASDAQ
68.78-1.63%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 11, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Aug 31, 20264Statement of changes in beneficial ownership
Aug 31, 20264Statement of changes in beneficial ownership
Aug 28, 20268-KCurrent report
Aug 18, 20264Statement of changes in beneficial ownership
Aug 13, 20268-KCurrent report
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 20264Statement of changes in beneficial ownership
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 30, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 23, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 14, 20264Statement of changes in beneficial ownership
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 532
Page
▼
/ 22